Leucémies Aiguës Myéloïdes FLT-3+ : un espoir thérapeutique ?
L'attesa per una nuova terapia per la Leucemia Mieloide Acuta. - Fondazione Gimema
Highlights dall'ASH 2020: Selezione degli abstracts più rilevanti in tema di leucemia mieloide acuta (LAM) – Ematologia in Progress
Composizione per uso nel trattamento della leucemia | Knowledgeshare
Malattie rare – Leucemia mieloide acuta, l'importanza dell'inibizione di FLT3 – I Malati Invisibili
Titolo Evento Luogo, data
LAM-003 display antileukemic activity in AML cells harboring FLT3-ITD... | Download Scientific Diagram
Discovery of a benzimidazole-based dual FLT3/TrKA inhibitor targeting acute myeloid leukemia - ScienceDirect
Therapeutic targeting of FLT3 in acute myeloid leukemia | OTT
La validazione del sistema prognostico ELN-2017: tra le conferme una positiva sorpresa. - Fondazione Gimema
Approvazione FDA di gilteritinib per la LAM recidivata o refrattaria con mutazione di FLT3 – Ematologia in Progress
Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia | EMBO Molecular Medicine
Composizione per uso nel trattamento della leucemia.
Cancers | Free Full-Text | Role of Biomarkers in FLT3 AML
Cancers | Free Full-Text | Overcoming Resistance: FLT3 Inhibitors Past, Present, Future and the Challenge of Cure
Diapositiva 1
Follow-up dei pazienti con LAM R/R FLT3-positiva trattati con gilteritinib: risultati a lungo termine dello studio di fase 3 ADMIRAL – Ematologia in Progress
![Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.3c00575/asset/images/acs.jmedchem.3c00575.social.jpeg_v03 "Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping | Journal of Medicinal Chemistry")
Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping | Journal of Medicinal Chemistry
FLT3 Inhibitors in Acute Myeloid Leukemia: Challenges and Recent Developments in Overcoming Resistance | Journal of Medicinal Chemistry
Discovery of benzimidazole-indazole derivatives as potent FLT3-tyrosine kinase domain mutant kinase inhibitors for acute myeloid leukemia,European Journal of Medicinal Chemistry - X-MOL
Follow-up dei pazienti con LAM R/R FLT3-positiva trattati con gilteritinib nello studio ADMIRAL – Ematologia in Progress
FLT3 inhibitors for acute myeloid leukemia: successes, defeats, and emerging paradigms - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D2MD00067A
ottobre 2015 - Significato prognostico delle mutazioni di NPM1 in assenza di FLT3-internal tandem duplication nei pazienti anziani con leucemia acuta mieloide: uno studio del gruppo SWOG e del gruppo UK National
LAM-003 display antileukemic activity in AML cells harboring FLT3-ITD... | Download Scientific Diagram
Therapeutic targeting of FLT3 in acute myeloid leukemia | OTT
Microenvironnement médullaire et résistance des LAM FLT3-ITD aux inhibiteurs de tyrosine kinase : Rôle pivot du récepteur TAM AXL | Semantic Scholar
Microenvironnement médullaire et résistance des LAM FLT3-ITD aux inhibiteurs de tyrosine kinase : Rôle pivot du récepteur TAM AXL | Semantic Scholar
Pharmacological impact of FLT3 mutations on receptor activity and responsiveness to tyrosine kinase inhibitors - ScienceDirect
NADPH oxidase mediated oxidative stress signaling in FLT3-ITD acute myeloid leukemia | Cell Death Discovery
